![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MAP1LC3B |
Gene summary for MAP1LC3B |
![]() |
Gene information | Species | Human | Gene symbol | MAP1LC3B | Gene ID | 81631 |
Gene name | microtubule associated protein 1 light chain 3 beta | |
Gene Alias | ATG8F | |
Cytomap | 16q24.2 | |
Gene Type | protein-coding | GO ID | GO:0000045 | UniProtAcc | Q658J6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
81631 | MAP1LC3B | LZE6T | Human | Esophagus | ESCC | 4.62e-13 | -4.16e-01 | 0.0845 |
81631 | MAP1LC3B | P1T-E | Human | Esophagus | ESCC | 6.46e-13 | 1.60e+00 | 0.0875 |
81631 | MAP1LC3B | P2T-E | Human | Esophagus | ESCC | 3.68e-35 | 8.46e-01 | 0.1177 |
81631 | MAP1LC3B | P4T-E | Human | Esophagus | ESCC | 2.27e-40 | 1.65e+00 | 0.1323 |
81631 | MAP1LC3B | P5T-E | Human | Esophagus | ESCC | 6.04e-50 | 1.49e+00 | 0.1327 |
81631 | MAP1LC3B | P8T-E | Human | Esophagus | ESCC | 1.19e-24 | 9.99e-01 | 0.0889 |
81631 | MAP1LC3B | P9T-E | Human | Esophagus | ESCC | 4.23e-09 | 5.74e-01 | 0.1131 |
81631 | MAP1LC3B | P10T-E | Human | Esophagus | ESCC | 2.79e-11 | 3.02e-01 | 0.116 |
81631 | MAP1LC3B | P11T-E | Human | Esophagus | ESCC | 7.56e-26 | 2.02e+00 | 0.1426 |
81631 | MAP1LC3B | P12T-E | Human | Esophagus | ESCC | 1.16e-57 | 1.90e+00 | 0.1122 |
81631 | MAP1LC3B | P15T-E | Human | Esophagus | ESCC | 1.28e-31 | 1.19e+00 | 0.1149 |
81631 | MAP1LC3B | P16T-E | Human | Esophagus | ESCC | 4.03e-16 | 5.81e-01 | 0.1153 |
81631 | MAP1LC3B | P17T-E | Human | Esophagus | ESCC | 1.58e-06 | 9.98e-01 | 0.1278 |
81631 | MAP1LC3B | P19T-E | Human | Esophagus | ESCC | 1.01e-12 | 1.68e+00 | 0.1662 |
81631 | MAP1LC3B | P20T-E | Human | Esophagus | ESCC | 1.26e-29 | 1.20e+00 | 0.1124 |
81631 | MAP1LC3B | P21T-E | Human | Esophagus | ESCC | 3.64e-48 | 1.55e+00 | 0.1617 |
81631 | MAP1LC3B | P22T-E | Human | Esophagus | ESCC | 8.02e-58 | 1.58e+00 | 0.1236 |
81631 | MAP1LC3B | P23T-E | Human | Esophagus | ESCC | 1.56e-40 | 1.72e+00 | 0.108 |
81631 | MAP1LC3B | P24T-E | Human | Esophagus | ESCC | 7.98e-29 | 9.49e-01 | 0.1287 |
81631 | MAP1LC3B | P26T-E | Human | Esophagus | ESCC | 5.67e-41 | 1.35e+00 | 0.1276 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00004226 | Breast | Precancer | autophagy of mitochondrion | 14/1080 | 81/18723 | 2.01e-04 | 3.16e-03 | 14 |
GO:00617266 | Breast | Precancer | mitochondrion disassembly | 14/1080 | 81/18723 | 2.01e-04 | 3.16e-03 | 14 |
GO:00316679 | Breast | Precancer | response to nutrient levels | 47/1080 | 474/18723 | 2.09e-04 | 3.27e-03 | 47 |
GO:00224119 | Breast | Precancer | cellular component disassembly | 44/1080 | 443/18723 | 3.17e-04 | 4.51e-03 | 44 |
GO:00714969 | Breast | Precancer | cellular response to external stimulus | 33/1080 | 320/18723 | 9.01e-04 | 1.03e-02 | 33 |
GO:00316688 | Breast | Precancer | cellular response to extracellular stimulus | 27/1080 | 246/18723 | 1.02e-03 | 1.13e-02 | 27 |
GO:00092677 | Breast | Precancer | cellular response to starvation | 19/1080 | 156/18723 | 1.65e-03 | 1.67e-02 | 19 |
GO:00425947 | Breast | Precancer | response to starvation | 22/1080 | 197/18723 | 2.30e-03 | 2.15e-02 | 22 |
GO:19030085 | Breast | Precancer | organelle disassembly | 15/1080 | 114/18723 | 2.31e-03 | 2.15e-02 | 15 |
GO:00316697 | Breast | Precancer | cellular response to nutrient levels | 22/1080 | 215/18723 | 6.58e-03 | 4.53e-02 | 22 |
GO:003166714 | Breast | IDC | response to nutrient levels | 62/1434 | 474/18723 | 2.33e-05 | 5.57e-04 | 62 |
GO:007149614 | Breast | IDC | cellular response to external stimulus | 45/1434 | 320/18723 | 5.40e-05 | 1.15e-03 | 45 |
GO:003166814 | Breast | IDC | cellular response to extracellular stimulus | 35/1434 | 246/18723 | 2.79e-04 | 4.26e-03 | 35 |
GO:000042212 | Breast | IDC | autophagy of mitochondrion | 15/1434 | 81/18723 | 1.13e-03 | 1.23e-02 | 15 |
GO:006172612 | Breast | IDC | mitochondrion disassembly | 15/1434 | 81/18723 | 1.13e-03 | 1.23e-02 | 15 |
GO:003166914 | Breast | IDC | cellular response to nutrient levels | 28/1434 | 215/18723 | 4.02e-03 | 3.25e-02 | 28 |
GO:190300812 | Breast | IDC | organelle disassembly | 17/1434 | 114/18723 | 5.99e-03 | 4.31e-02 | 17 |
GO:007149623 | Breast | DCIS | cellular response to external stimulus | 45/1390 | 320/18723 | 2.55e-05 | 5.87e-04 | 45 |
GO:003166723 | Breast | DCIS | response to nutrient levels | 58/1390 | 474/18723 | 1.16e-04 | 2.03e-03 | 58 |
GO:003166822 | Breast | DCIS | cellular response to extracellular stimulus | 35/1390 | 246/18723 | 1.54e-04 | 2.59e-03 | 35 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501416 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0513118 | Breast | Precancer | Shigellosis | 44/684 | 247/8465 | 3.91e-07 | 6.86e-06 | 5.26e-06 | 44 |
hsa0516718 | Breast | Precancer | Kaposi sarcoma-associated herpesvirus infection | 36/684 | 194/8465 | 1.68e-06 | 2.53e-05 | 1.94e-05 | 36 |
hsa0421610 | Breast | Precancer | Ferroptosis | 11/684 | 41/8465 | 2.95e-04 | 2.45e-03 | 1.88e-03 | 11 |
hsa0413716 | Breast | Precancer | Mitophagy - animal | 15/684 | 72/8465 | 5.22e-04 | 3.93e-03 | 3.01e-03 | 15 |
hsa0501417 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0513119 | Breast | Precancer | Shigellosis | 44/684 | 247/8465 | 3.91e-07 | 6.86e-06 | 5.26e-06 | 44 |
hsa0516719 | Breast | Precancer | Kaposi sarcoma-associated herpesvirus infection | 36/684 | 194/8465 | 1.68e-06 | 2.53e-05 | 1.94e-05 | 36 |
hsa0421613 | Breast | Precancer | Ferroptosis | 11/684 | 41/8465 | 2.95e-04 | 2.45e-03 | 1.88e-03 | 11 |
hsa0413717 | Breast | Precancer | Mitophagy - animal | 15/684 | 72/8465 | 5.22e-04 | 3.93e-03 | 3.01e-03 | 15 |
hsa0501423 | Breast | IDC | Amyotrophic lateral sclerosis | 102/867 | 364/8465 | 1.29e-22 | 5.22e-21 | 3.91e-21 | 102 |
hsa0502223 | Breast | IDC | Pathways of neurodegeneration - multiple diseases | 116/867 | 476/8465 | 3.63e-20 | 1.18e-18 | 8.82e-19 | 116 |
hsa0513124 | Breast | IDC | Shigellosis | 47/867 | 247/8465 | 1.78e-05 | 2.00e-04 | 1.49e-04 | 47 |
hsa0516723 | Breast | IDC | Kaposi sarcoma-associated herpesvirus infection | 38/867 | 194/8465 | 5.87e-05 | 5.96e-04 | 4.46e-04 | 38 |
hsa0421623 | Breast | IDC | Ferroptosis | 12/867 | 41/8465 | 5.87e-04 | 4.89e-03 | 3.66e-03 | 12 |
hsa0413723 | Breast | IDC | Mitophagy - animal | 17/867 | 72/8465 | 7.61e-04 | 6.04e-03 | 4.52e-03 | 17 |
hsa0501433 | Breast | IDC | Amyotrophic lateral sclerosis | 102/867 | 364/8465 | 1.29e-22 | 5.22e-21 | 3.91e-21 | 102 |
hsa0502233 | Breast | IDC | Pathways of neurodegeneration - multiple diseases | 116/867 | 476/8465 | 3.63e-20 | 1.18e-18 | 8.82e-19 | 116 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MAP1LC3B | insertion | Frame_Shift_Ins | novel | c.314_315insAG | p.Asp106GlufsTer17 | p.D106Efs*17 | Q9GZQ8 | protein_coding | TCGA-EA-A44S-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | ||
MAP1LC3B | SNV | Missense_Mutation | c.116A>G | p.Lys39Arg | p.K39R | Q9GZQ8 | protein_coding | tolerated(0.24) | benign(0.265) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MAP1LC3B | SNV | Missense_Mutation | rs775971070 | c.110N>A | p.Arg37Gln | p.R37Q | Q9GZQ8 | protein_coding | deleterious(0) | probably_damaging(0.965) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
MAP1LC3B | SNV | Missense_Mutation | novel | c.208N>T | p.Arg70Cys | p.R70C | Q9GZQ8 | protein_coding | deleterious(0.05) | benign(0.164) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MAP1LC3B | SNV | Missense_Mutation | c.62G>A | p.Arg21Gln | p.R21Q | Q9GZQ8 | protein_coding | tolerated(0.6) | benign(0.011) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
MAP1LC3B | SNV | Missense_Mutation | c.112T>C | p.Tyr38His | p.Y38H | Q9GZQ8 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MAP1LC3B | SNV | Missense_Mutation | novel | c.128N>G | p.Gln43Arg | p.Q43R | Q9GZQ8 | protein_coding | tolerated(0.29) | possibly_damaging(0.798) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
MAP1LC3B | SNV | Missense_Mutation | rs775971070 | c.110G>A | p.Arg37Gln | p.R37Q | Q9GZQ8 | protein_coding | deleterious(0) | probably_damaging(0.965) | TCGA-44-A47A-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
MAP1LC3B | insertion | Nonsense_Mutation | novel | c.367_368insATTGACAACAA | p.Leu123TyrfsTer2 | p.L123Yfs*2 | Q9GZQ8 | protein_coding | TCGA-86-8669-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR | ||
MAP1LC3B | SNV | Missense_Mutation | novel | c.166N>A | p.Asp56Asn | p.D56N | Q9GZQ8 | protein_coding | tolerated(0.08) | probably_damaging(1) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |